These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 28229220)
1. Overexpression of HepaCAM inhibits bladder cancer cell proliferation and viability through the AKT/FoxO pathway. Tang M; Zhao Y; Liu N; Chen E; Quan Z; Wu X; Luo C J Cancer Res Clin Oncol; 2017 May; 143(5):793-805. PubMed ID: 28229220 [TBL] [Abstract][Full Text] [Related]
2. Evidence for AKT-independent regulation of FOXO1 and FOXO3 in haematopoietic stem and progenitor cells. Liang R; Rimmelé P; Bigarella CL; Yalcin S; Ghaffari S Cell Cycle; 2016; 15(6):861-7. PubMed ID: 26929388 [TBL] [Abstract][Full Text] [Related]
3. The SMAD2/3 pathway is involved in hepaCAM-induced apoptosis by inhibiting the nuclear translocation of SMAD2/3 in bladder cancer cells. Wang X; Chen E; Tang M; Yang X; Wang Y; Quan Z; Wu X; Luo C Tumour Biol; 2016 Aug; 37(8):10731-43. PubMed ID: 26873485 [TBL] [Abstract][Full Text] [Related]
4. MiR-1/GOLPH3/Foxo1 Signaling Pathway Regulates Proliferation of Bladder Cancer. Liu MK; Ma T; Yu Y; Suo Y; Li K; Song SC; Zhang W Technol Cancer Res Treat; 2019; 18():1533033819886897. PubMed ID: 31714185 [TBL] [Abstract][Full Text] [Related]
5. A novel function of FoxO transcription factors in thrombin-stimulated vascular smooth muscle cell proliferation. Mahajan SG; Fender AC; Meyer-Kirchrath J; Kurt M; Barth M; Sagban TA; Fischer JW; Schrör K; Hohlfeld T; Rauch BH Thromb Haemost; 2012 Jul; 108(1):148-58. PubMed ID: 22552808 [TBL] [Abstract][Full Text] [Related]
6. MicroRNA-608 inhibits proliferation of bladder cancer via AKT/FOXO3a signaling pathway. Liang Z; Wang X; Xu X; Xie B; Ji A; Meng S; Li S; Zhu Y; Wu J; Hu Z; Lin Y; Zheng X; Xie L; Liu B Mol Cancer; 2017 May; 16(1):96. PubMed ID: 28549468 [TBL] [Abstract][Full Text] [Related]
7. FoxO proteins' nuclear retention and BH3-only protein Bim induction evoke mitochondrial dysfunction-mediated apoptosis in berberine-treated HepG2 cells. Shukla S; Rizvi F; Raisuddin S; Kakkar P Free Radic Biol Med; 2014 Nov; 76():185-99. PubMed ID: 25128467 [TBL] [Abstract][Full Text] [Related]
8. Exploration of the correlations between interferon-γ in patient serum and HEPACAM in bladder transitional cell carcinoma, and the interferon-γ mechanism inhibiting BIU-87 proliferation. Xu B; He Y; Wu X; Luo C; Liu A; Zhang J J Urol; 2012 Oct; 188(4):1346-53. PubMed ID: 22906662 [TBL] [Abstract][Full Text] [Related]
9. hepaCAM and p-mTOR closely correlate in bladder transitional cell carcinoma and hepaCAM expression inhibits proliferation via an AMPK/mTOR dependent pathway in human bladder cancer cells. Wang Q; Luo C; Wu X; Du H; Song X; Fan Y J Urol; 2013 Nov; 190(5):1912-8. PubMed ID: 23669565 [TBL] [Abstract][Full Text] [Related]
10. Resveratrol induces growth arrest and apoptosis through activation of FOXO transcription factors in prostate cancer cells. Chen Q; Ganapathy S; Singh KP; Shankar S; Srivastava RK PLoS One; 2010 Dec; 5(12):e15288. PubMed ID: 21179458 [TBL] [Abstract][Full Text] [Related]
11. FOXO1 and FOXO3a sensitize non-small-cell lung cancer cells to cisplatin-induced apoptosis independent of Bim. Sun T; Zhang J; Deng B; Fan X; Long T; Jin H; Tao S; Kang P; Tan Q Acta Biochim Biophys Sin (Shanghai); 2020 Dec; 52(12):1348-1359. PubMed ID: 33167006 [TBL] [Abstract][Full Text] [Related]
12. LukS-PV inhibits the proliferation of hepatocellular carcinoma cells by maintaining FOXO3 stability via the PI3K/AKT signaling pathway. Nie Z; Shi L; Song K; Xu X; Ding P; Lu B; Wu G; Ma X Cell Signal; 2022 Jul; 95():110357. PubMed ID: 35589047 [TBL] [Abstract][Full Text] [Related]
13. Phosphatidylinositol 3-kinase inhibitor LY294002 suppresses proliferation and sensitizes doxorubicin chemotherapy in bladder cancer cells. Wu D; Tao J; Xu B; Qing W; Li P; Lu Q; Zhang W Urol Int; 2011; 87(1):105-13. PubMed ID: 21597260 [TBL] [Abstract][Full Text] [Related]
14. 5-azacytidine inhibits the proliferation of bladder cancer cells via reversal of the aberrant hypermethylation of the hepaCAM gene. Wang X; Chen E; Yang X; Wang Y; Quan Z; Wu X; Luo C Oncol Rep; 2016 Mar; 35(3):1375-84. PubMed ID: 26677113 [TBL] [Abstract][Full Text] [Related]
15. Phosphatidylinositol 3-kinase inhibitor LY294002 suppresses proliferation and sensitizes doxorubicin chemotherapy in bladder cancer cells. Wu D; Tao J; Xu B; Qing W; Li P; Lu Q; Zhang W Urol Int; 2011; 86(3):346-54. PubMed ID: 21273759 [TBL] [Abstract][Full Text] [Related]
16. Regulation of cardiomyocyte proliferation and myocardial growth during development by FOXO transcription factors. Evans-Anderson HJ; Alfieri CM; Yutzey KE Circ Res; 2008 Mar; 102(6):686-94. PubMed ID: 18218983 [TBL] [Abstract][Full Text] [Related]
17. Nuclear forkhead box O3a accumulation contributing to the proliferative suppression in liver cancer cells by PI3K/Akt signaling pathway. Hou Y; Sun G; Jiang X; Zhu Z; Yang J J Cancer Res Ther; 2018 Dec; 14(Supplement):S1124-S1128. PubMed ID: 30539857 [TBL] [Abstract][Full Text] [Related]
18. Down-regulation of miR-29c in human bladder cancer and the inhibition of proliferation in T24 cell via PI3K-AKT pathway. Fan Y; Song X; Du H; Luo C; Wang X; Yang X; Wang Y; Wu X Med Oncol; 2014 Jul; 31(7):65. PubMed ID: 24952510 [TBL] [Abstract][Full Text] [Related]
19. Decreased PKG transcription mediated by PI3K/Akt/FoxO1 pathway is involved in the development of nitroglycerin tolerance. An YM; Li YJ; Zhang CL; Cong X; Gao YS; Wu LL; Dou D Biochem Biophys Res Commun; 2019 Jan; 508(4):1195-1201. PubMed ID: 30554658 [TBL] [Abstract][Full Text] [Related]
20. FOXO3 is a latent tumor suppressor for FOXO3-positive and cytoplasmic-type gastric cancer cells. Tsuji T; Maeda Y; Kita K; Murakami K; Saya H; Takemura H; Inaki N; Oshima M; Oshima H Oncogene; 2021 Apr; 40(17):3072-3086. PubMed ID: 33795838 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]